Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score

AIM: TNF inhibitor drugs are a treatment option for rheumatoid arthritis, but response is not universal. Response is typically measured using the composite 4-component (4C) disease activity score 28 (DAS28) which contains more subjective measures. This study used a validated 2-component (2C) DAS28 s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacogenomics
Asıl Yazarlar: Gilani, Syed SA, Nair, Nisha, Plant, Darren, Hyrich, Kimme, Morgan, Ann W, Morris, Andrew P, Wilson, Anthony G, Isaacs, John D, Barton, Anne, Bluett, James
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Future Medicine Ltd 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649675/
https://ncbi.nlm.nih.gov/pubmed/33124499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2020-0043
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller